AKTX Stock Summary and Trading Ideas (Akari Therapeutics PLC - American Depositary Shares | NASDAQ:AKTX)

Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA).

Akari Therapeutics PLC - American Depositary Shares trades on the NASDAQ stock market under the symbol AKTX.

As of October 23, 2024, AKTX stock price climbed to $2.21 with 1,940 million shares trading.

AKTX has a market cap of $26.84 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, AKTX traded as high as $35.40 and as low as $1.08.

AKTX has underperformed the market in the last year with a price return of -35.0% while the SPY ETF gained +38.9%. AKTX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -43.0% and -27.8%, respectively, while the SPY returned +4.5% and +0.8%, respectively.

AKTX support price is $1.91 and resistance is $2.36 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AKTX shares will trade within this expected range on the day.